Best for
Mobile
How to buy Diaceutics shares | 130p
Own Diaceutics shares in just a few minutes.
Diaceutics PLC is a biotechnology business based in the UK. Diaceutics shares (DXRX.LSE) are listed on the London Stock Exchange (LSE) and all prices are listed in pence sterling. Its last market close was 130p – a decrease of 3.35% over the previous week. Diaceutics employs 128 staff and has a trailing 12-month revenue of around £14.4 million.
How to buy shares in Diaceutics
- Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: DXRX in this case.
- Research Diaceutics shares. The platform should provide the latest information available.
- Buy your Diaceutics shares. It's that simple.
What's in this guide?
- Can I buy shares in Diaceutics?
- Has coronavirus impacted Diaceutics shares?
- Diaceutics shares summary
- Compare share dealing platforms
- Is Diaceutics stock a buy or sell?
- Diaceutics performance over time
- Are Diaceutics shares over-valued?
- Diaceutics's financials
- Does Diaceutics pay a dividend?
- Other common questions
How has Coronavirus impacted Diaceutics's share price?
Since the stock market crash in March caused by coronavirus, Diaceutics's share price has had significant negative movement.
Its last market close was 130p, which is 14.19% down on its pre-crash value of 151.5p and 22.36% up on the lowest point reached during the March crash when the shares fell as low as 106.24p.
If you had bought £1,000 worth of Diaceutics shares at the start of February 2020, those shares would have been worth £957.85 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth £996.16.
Diaceutics share price
Use our graph to track the performance of DXRX stocks over time.Diaceutics shares at a glance
Information last updated 2020-12-27.
| Latest market close | 130p |
|---|---|
| 52-week range | 101.6p - 195p |
| 50-day moving average | 131.0294p |
| 200-day moving average | 144.7641p |
| PE ratio | 25.2222 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | 4.5p |
Invest in Diaceutics shares with 0% commission
Other fees may apply. Your capital is at risk.
- Unlimited trades, with no dealing charges or management fees
- If your trades get copied you can earn extra money
- Create an account today in a few minutes
Go to site
Capital at risk
Share dealing platform comparison
Table: sorted by promoted deals first
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Is it a good time to buy Diaceutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Diaceutics price performance over time
Historical closes compared with the last close of 130p
| 1 week (2021-01-13) | -14.47% |
|---|---|
| 1 month (2020-12-23) | 12.55% |
| 3 months (2020-10-23) | 8.11% |
| 6 months (2020-07-21) | -21.21% |
| 1 year (2020-01-21) | 10.64% |
|---|
Is Diaceutics under- or over-valued?
Valuing Diaceutics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Diaceutics's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Diaceutics's P/E ratio
Diaceutics's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 25x. In other words, Diaceutics shares trade at around 25x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the FTSE 250 at the end of September 2019 (19.71). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Diaceutics's EBITDA
Diaceutics's EBITDA (earnings before interest, taxes, depreciation and amortisation) is £2.8 million.
The EBITDA is a measure of a Diaceutics's overall financial performance and is widely used to measure a its profitability.
Diaceutics financials
| Revenue TTM | £14.4 million |
|---|---|
| Operating margin TTM | 17.08% |
| Gross profit TTM | £10.3 million |
| Return on assets TTM | 4.9% |
| Return on equity TTM | 10.83% |
| Profit margin | 22.32% |
| Book value | 0.489p |
| Market capitalisation | £95.4 million |
TTM: trailing 12 months
Diaceutics share dividends
We're not expecting Diaceutics to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
Win £500 to get your trading started
Subscribe to trending stock alerts for a chance to win
Diaceutics overview
Diaceutics Plc provides data, data analytics, and implementation services for pharmaceutical companies worldwide. It offers diagnostic landscape services, such as patient journey, lab mapping, diagnostic regulation, turnaround time, and sample availability analysis services; diagnostic tracking services, including lab tracking, patient insights, and physician segmentation services; and diagnostic payers research, diagnostic clinical landscape, integrated mapping research, buying process research, and testers/non-testers research services. The company also provides diagnostic planning services consisting of strategic and tactical planning, launch planning, diagnostic partner selection, and financial forecast services; commercialization services comprising content creation; LabEd/workshops, diagnostic adboards, conference support, and proficiency testing services; and Diagnostic reimbursement services. Diaceutics Plc was founded in 2005 and is headquartered in Belfast, the United Kingdom.
Frequently asked questions
More guides on Finder
-
How to buy Diaceutics shares
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Charlie’s Holdings shares
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Lemonade shares | $50.05
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Unity Software shares | $111.51
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
-
How to buy FuelCell Energy shares | $3.745
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Diaceutics shares | $0.1275
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
-
How to buy Zomedica Pharmaceuticals shares | $0.93
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
-
How to buy YRC Worldwide shares | $4.66
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
-
How to buy Xeros Technology Group shares | 220p
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
-
How to buy Xpediator shares | 33.5p
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.
Ask an Expert